Navigation Links
Phosphagenics Announces Initiation of Phase 1 Clinical Trial in Humans for Its Transdermal Lidocaine
Date:9/23/2008

MELBOURNE, Australia, Sept. 23 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; AIM: PSG; OTCQX: PPGNY) announced today that it has initiated a phase 1 human clinical trial using its patented drug delivery system, TPM, for the targeted delivery of a leading pain relief drug, lidocaine. The trial will compare the dermal bioavailability and will measure the systemic exposure of lidocaine in one of the leading marketed products, Xylocaine(R) (5% lidocaine), and Phosphagenics' lidocaine (5% lidocaine).

Earlier this year, the Company's pre-clinical results demonstrated that through the utilisation of Phosphagenics' patented lidocaine formulation, skin concentration of lidocaine was approximately 900% higher 5 hours after topical application as compared to Xylocaine(R). In addition, Phosphagenics' lidocaine was able to significantly increase the depth of lidocaine penetration by approximately 500% in the thigh muscle of animals treated compared to Xylocaine(R).

Dr. Esra Ogru, Executive Vice President of Research and Development at Phosphagenics, said; "Lidocaine is a well known topical anaesthetic used for a wide variety of ailments, including temporary relief of rashes, stings, sprains, strains, bites, and burns. However, it has poor penetration into the dermis, frequently rendering it largely ineffective."

"Our pre-clinical study showed that Phosphagenics' lidocaine formulation has the potential to provide patients with rapid pain relief, while not increasing systemic exposure, and we are excited to continue moving this program forward efficiently," she said.

This most recent trial is being conducted at the Centre for Pharmaceutical Research, University of South Australia, under the guidance of Dr. David Foster, as the Principal Investigator. It is an open label, single centre bioavailability trial of dermal and systemic pharmacokinetics in 12 healthy adult volunteers incorporating secondary endpoints of saf
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
2. Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
3. Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
4. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
5. Nestle Nutrition and Phosphagenics to Commence Phospha E(R) Phase 2 Clinical Trial
6. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
7. Phosphagenics to Commence Phase 2 TPM/Insulin Clinical Trial
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
10. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 ResMed (NYSE: ... patent infringement action against Chinese medical device manufacturer BMC Medical ... ruled today that BMC,s masks listed below infringe ResMed,s patents, ... selling these masks in the United States ... N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)... 2014  The American Diabetes Association is recommending ... people with diabetes and that all people with ... statins, in keeping with recent changes to guidelines ... College of Cardiology (ACC) and American Heart Association ... recent changes to the Association,s annual revised Standards ...
(Date:12/22/2014)... N.J. , Dec. 22, 2014  CytoSorbents ... marketing its CytoSorb® blood purification technology to help ... patients in 28 countries worldwide, today announced the ... , MD, FACS, as its Senior Vice President ... Dr. Di Russo is ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... Health Media, LLC (AHM) has acquired Ephikacy, LLC, the ... the pharmaceutical and life sciences industries. , Advanced Health ... supplying automation and compliance management systems to more than ... than 200 brands. The addition of Ephikacy,s product ...
... Anderson Independent Mail reported that the Partnership ... Anderson and Seneca, South Carolina last month. , The ... America (PhRMA), travels around the country helping people get ... was grateful the bus stopped in Anderson. She and her husband ...
Cached Medicine Technology:Advanced Health Media Announces Acquisition of Ephikacy, LLC 2Advanced Health Media Announces Acquisition of Ephikacy, LLC 3'Help is Here Express' Arrives in Anderson, Seneca 2
(Date:12/24/2014)... 24, 2014 For chic ladies, new fashionable ... a part of their Holiday Wish List, Angeldress.co.uk ... perfect ways to accent ladies’ holiday wardrobe by launching a ... be all over the discount of 80% off, like a ... to ship. The company’s chic wedding dresses are among the ...
(Date:12/24/2014)... Albany, NY (PRWEB) December 24, 2014 ... market with regards to the various market dynamics such ... of robot assisted arthroscopy, the wait time for U.S. ... the sports medicine market, and the challenges faced by ... at: http://www.researchmoz.us/global-sports-medicine-market-report-2014-edition-report.html , The report also provides ...
(Date:12/24/2014)... FL (PRWEB) December 24, 2014 Dental ... solution for a tooth replacement. They offer the strongest ... several advantages over other forms of tooth replacement. They ... rely on the adjacent teeth for support, and they ... people have been told that they are not suitable ...
(Date:12/24/2014)... Aliso Viejo, California (PRWEB) December 24, 2014 ... the release of the ProDenoise from Pixel Film Studios. , ... film noise or grain in their footage,” said Christina Austin, ... to have in any Final Cut Pro X editors toolbox.” ... subdue film noise or grain in their footage with ProDenoise ...
(Date:12/24/2014)... Dennis Thompson HealthDay ... There,s good news about the experimental Ebola vaccine that U.S. ... research shows a precursor of that vaccine produced a ... version of the vaccine, when given to more than 100 ... and white blood cells that could potentially protect a person ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:Sports Medicine Market Report 2014: Global Industry Analysis, Share, Size, Trends, Growth and Forecast report 2Health News:Innovative Dental Implant Procedure to Gain Momentum in the New Year 2Health News:Pixel Film Studios released the ProDenoise plugin for Final Cut Pro X today. 2Health News:Early Study Offers Hope for an Ebola Vaccine 2Health News:Early Study Offers Hope for an Ebola Vaccine 3Health News:Early Study Offers Hope for an Ebola Vaccine 4
... sleeping five hours or less per day when their babies ... substantial weight retention (11 pounds or more) at their babys ... according to a new study by Kaiser Permanente and Harvard ... The study, published in the November issue of the American ...
... Optimal Nutrition Inc. Chooses ,it, Girl PR to help promote ... ... 19 "it" Girl Public relations, one of,the leading Public ... addition of Optimal Nutrition Inc. (O.N.I.).,O.N.I. bestows a customized door-to-door ...
... to Offer Innovative Coverage Options, Expand Agency ... Representation in Massachusetts -, ... THG ), a leading writer of auto, home and,business ... Insurance approval to offer an enhanced auto product that will,deliver ...
... 19 CorVel Corporation,(Nasdaq: CRVL ) today ... common stock under the stock repurchase program previously ... 2006, the Board had approved a,1,500,000 share expansion ... Company has repurchased 862,323 shares, with a remaining ...
... also made, MINNEAPOLIS, Nov. 19 At ... of Directors of ClearWay Minnesota approved 11,grants for ... to Breathe Act,s,impact on young adults to interventions ... Chicano Latino youth and African,immigrants. ClearWay Minnesota will ...
... Brings Global U.N. Environment Initiative to Northern ... Education,Activities, MORRISTOWN, N.J., Nov. 18, 2007 ... responsibility, today Bayer,employee-volunteers and Girl Scouts from ... their sleeves, grabbed their spades and planted ...
Cached Medicine News:Health News:Kaiser Permanente/Harvard Medical School study links lack of sleep to weight gain for new moms 2Health News:'it' Girl Public Relations Adds 'O.N.I.' New Organic Food Delivery Service to Its Lifestyle Division 2Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 2Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 3Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 4Health News:CorVel Corporation Announces Resumption of Stock Repurchases 2Health News:CorVel Corporation Announces Resumption of Stock Repurchases 3Health News:ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants 2Health News:ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants 3Health News:Bayer Awards Making Science Make Sense Grant to Girl Scouts 2Health News:Bayer Awards Making Science Make Sense Grant to Girl Scouts 3Health News:Bayer Awards Making Science Make Sense Grant to Girl Scouts 4Health News:Bayer Awards Making Science Make Sense Grant to Girl Scouts 5
The Tissue Approximating Forceps are to aid in the approximating of the tissue edges....
The Auto Suture™ SIGNET™ staplers place one staple each time the instrument handles are squeezed. The staples first penetrate the skin and are then formed, thus holding the tissue togethe...
The Auto Suture DFS stapler is a disposable fascia stapler. The stapler places one staple each time the instrument handles are activated. The staples first penetrate the fascia and are then formed, t...
... is a full-feature skin stapler with a ... has improved visibility over existing fixed-head skin ... for easier staple placement., ,This Skin ... instrument designed to deliver rectangular, stainless steel ...
Medicine Products: